An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
Clinical trial NCT06169579 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06169579
- Sponsor
- Shenzhen NewDEL Biotech, Co., Ltd
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-04
- Primary completion
- 2025-12-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.